ADC Therapeutics logo

ADC Therapeutics

ADC Therapeutics is a commercial-stage biotechnology company improving the lives of those affected by cancer with our next-generation, targeted antibody drug conjugates (ADCs). With an ADC platform validated by the FDA approval of ZYNLONTA® and a deep understanding of the oncology treatment landscape, we are working to address significant unmet medical needs and improve outcomes for those with difficult-to-treat hematological cancers and solid tumors. Founded in 2011, ADC Therapeutics is based in Lausanne, Switzerland, with operations in London (R&D), New Jersey (Clinical and Commercial), and the San Francisco Bay Area (CMC). Our highly skilled global team is committed to confronting cancer with the full potential of our science, bringing unique, targeted therapies and hope to patients and their families. For more information, please visit https://www.adctherapeutics.com/ and follow us on Twitter @adctherapeutics.

Free account • No credit card • 5 profiles/day

Biotechnology Research 266 Employees Found Lausanne, Switzerland Founded 2011 10 Similar Companies
266 Employees Found
92% Email Coverage
$80.0M Est Revenue
2 Office HQ
10 Similar Companies
Jun '26 Last Verified

Frequently asked questions about ADC Therapeutics

What is ADC Therapeutics email format?

The widely used ADC Therapeutics email format is {first}.{last} (e.g. john.smith@adctherapeutics.com) with 100% adoption across the company.

What is ADC Therapeutics customer service number?

To contact ADC Therapeutics customer service number in your country click here to find.

Who is the CEO of ADC Therapeutics?

James Boston is the CEO of ADC Therapeutics.

Who are the decision makers in ADC Therapeutics?

The decision makers in ADC Therapeutics are Ron Squarer, James Boston, David Ege, etc. Click to Find ADC Therapeutics decision makers emails.